Xenon Pharmaceuticals (XENE) Stock Chart & Stock Price History $30.50 -0.04 (-0.13%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$30.51 +0.01 (+0.03%) As of 08/1/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Xenon Pharmaceuticals Stock Price Performance The Xenon Pharmaceuticals (XENE) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 29.35%, with a year-to-date return of -22.19%. In the past month, the stock has decreased 8.60%, reflecting recent market activity. As of the latest close, Xenon Pharmaceuticals traded at $30.50 with a market cap of $2.34 billion and volume of 754,163 shares. Five years ago, the stock traded at $10.93, representing a 179.05% increase over that period. At the time, it had a market cap of $382.22 million and a volume of 143,800 shares. Receive XENE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Xenon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.52%1 Month Performance-8.60%3 Month Performance-20.32%Year-To-Date Performance-22.19%1 Year Performance-29.35%5 Year Performance+179.05% XENE Stock Chart for Saturday, August, 2, 2025 XENE Chart by TradingView Xenon Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/01/2025$30.54$30.50-0.13%$30.74$30.00754,163 shs$2.34 billion07/31/2025$30.77$30.54-0.75%$31.30$30.28680,363 shs$2.34 billion07/30/2025$30.87$30.77-0.32%$31.87$30.56700,750 shs$2.36 billion07/29/2025$30.97$30.87-0.32%$31.56$30.47915,884 shs$2.37 billion07/28/2025$30.30$30.97+2.21%$31.05$30.001.31 million shs$2.38 billion07/25/2025$31.01$30.30-2.29%$31.39$30.24969,939 shs$2.33 billion07/24/2025$31.19$31.01-0.58%$31.45$30.84570,070 shs$2.38 billion07/23/2025$31.33$31.19-0.45%$31.82$30.84591,861 shs$2.39 billion07/22/2025$31.49$31.33-0.51%$31.98$31.12796,721 shs$2.40 billion07/21/2025$31.59$31.49-0.32%$32.32$31.40775,396 shs$2.42 billion Get the Latest News and Ratings for XENE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Xenon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/18/2025$32.12$31.59-1.65%$32.72$31.501.05 million shs$2.42 billion07/17/2025$31.62$32.12+1.58%$32.41$31.63639,424 shs$2.46 billion07/16/2025$31.48$31.62+0.44%$32.10$31.15938,574 shs$2.43 billion07/15/2025$32.60$31.48-3.44%$32.79$31.40896,849 shs$2.42 billion07/14/2025$32.21$32.60+1.21%$33.23$32.20618,806 shs$2.50 billion07/11/2025$32.98$32.21-2.33%$33.15$32.10595,207 shs$2.47 billion07/10/2025$32.68$32.98+0.92%$33.36$32.09732,810 shs$2.53 billion07/09/2025$31.42$32.68+4.01%$33.51$31.651.26 million shs$2.51 billion07/08/2025$31.83$31.42-1.29%$32.24$31.22874,082 shs$2.41 billion07/07/2025$34.70$31.83-8.28%$33.12$31.64713,324 shs$2.44 billion07/04/2025$34.70$34.70$33.83$33.06492,450 shs$2.66 billion07/03/2025$33.37$34.70+4.00%$33.83$33.06492,450 shs$2.66 billion07/02/2025$32.09$33.37+3.99%$33.44$31.901.28 million shs$2.56 billion07/01/2025$31.30$32.09+2.52%$32.53$31.091.60 million shs$2.46 billion Related Companies Verona Pharma PLC American Depositary Share Stock Price Chart BridgeBio Pharma Stock Price Chart Blueprint Medicines Stock Price Chart Roivant Sciences Stock Price Chart Legend Biotech Stock Price Chart Elanco Animal Health Stock Price Chart Regencell Bioscience Stock Price Chart Revolution Medicines Stock Price Chart Grifols Stock Price Chart TG Therapeutics Stock Price Chart Receive XENE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Xenon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:XENE) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredOne stock to replace NvidiaInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xenon Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Xenon Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.